Biomea Fusion (BMEA) announced its presentations at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management in Singapore, 18-20 November. Biomea will showcase three oral ...

GSA Capital Partners LLP lowered its stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) by 36.8% during the third quarter, according to the company in its most recent disclosure with ...

One demographic of teachers in particular are experiencing a sharp decline and a local Detroit-based organization is working ...

Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. So, the natural question for Biomea Fusion (NASDAQ:BMEA) ...

If you are a vessel tracker or a reader who has submitted a photo of a ship to The Westshore, you may have noticed the fully laden Ever Steady, Marcos V, MSC Sofia Paz, and the Conti Contessa anchored ...

Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “the Company”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral ...

Biomea Fusion Inc. (NASDAQ:BMEA), a biotechnology company focused on developing innovative treatments for diabetes and obesity, finds itself at a critical juncture as it navigates regulatory ...

LOS ANGELES, CA / ACCESSWIRE / November 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea Fusion, ...

On Thursday, Biomea Fusion Inc (BMEA) stock saw a decline, ending the day at $9.37 which represents a decrease of $-0.97 or -9.38% from the prior close of $10.34. The stock opened at $10.46 and ...

On Friday, Truist Securities upgraded Biomea Fusion Inc. (NASDAQ:BMEA) stock from Hold to Buy, setting a new price target at $54.00. The adjustment comes after the clinical hold ...

REDWOOD CITY, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA) (“Biomea” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery and ...